|
Volumn 387, Issue 10032, 2016, Pages 1970-
|
Hepatitis C: Global ambition, national realities
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
INTERFERON;
CANCER MORTALITY;
DEATH;
DRUG COST;
EDITORIAL;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LIVER CANCER;
PRIORITY JOURNAL;
WORLD HEALTH ORGANIZATION;
ECONOMICS;
HEALTH;
HEALTH CARE PLANNING;
HEPATITIS C, CHRONIC;
MORTALITY;
ANTIVIRAL AGENTS;
DRUG COSTS;
GLOBAL HEALTH;
HEALTH PRIORITIES;
HEPATITIS C, CHRONIC;
HUMANS;
|
EID: 84967143860
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(16)30520-7 Document Type: Editorial |
Times cited : (3)
|
References (0)
|